Gilead Sciences, Inc.
LONG-ACTING FORMULATIONS OF TENOFOVIR ALAFENAMIDE

Last updated:

Abstract:

The present disclosure provides long-acting formulations of tenofovir alafenamide, methods of making the same and methods of using the same.

Status:
Application
Type:

Utility

Filling date:

17 Jul 2020

Issue date:

18 Aug 2022